0.00Open0.00Pre Close0 Volume0 Open Interest2.50Strike Price0.00Turnover1101.77%IV-85.54%PremiumDec 20, 2024Expiry Date14.79Intrinsic Value100Multiplier5DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9842Delta0.0018Gamma1.15Leverage Ratio-0.0840Theta0.0003Rho1.13Eff Leverage0.0008Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet